Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark flag Denmark · Delayed Price · Currency is DKK
2.810
-0.050 (-1.75%)
May 27, 2026, 4:42 PM CET

CPH:SMSMED Statistics

Total Valuation

CPH:SMSMED has a market cap or net worth of DKK 79.53 million. The enterprise value is 152.06 million.

Market Cap79.53M
Enterprise Value 152.06M

Important Dates

The next estimated earnings date is Friday, May 29, 2026.

Earnings Date May 29, 2026
Ex-Dividend Date n/a

Share Statistics

CPH:SMSMED has 27.81 million shares outstanding.

Current Share Class 27.81M
Shares Outstanding 27.81M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.33%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE 57.20
PS Ratio 0.37
PB Ratio 1.09
P/TBV Ratio 1.09
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 51.23, with an EV/FCF ratio of -6.44.

EV / Earnings -19.90
EV / Sales 0.71
EV / EBITDA 51.23
EV / EBIT n/a
EV / FCF -6.44

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.02.

Current Ratio 1.46
Quick Ratio 0.27
Debt / Equity 1.02
Debt / EBITDA 24.93
Debt / FCF -3.13
Interest Coverage -2.19

Financial Efficiency

Return on equity (ROE) is -9.97% and return on invested capital (ROIC) is -4.69%.

Return on Equity (ROE) -9.97%
Return on Assets (ROA) -2.25%
Return on Invested Capital (ROIC) -4.69%
Return on Capital Employed (ROCE) -6.32%
Weighted Average Cost of Capital (WACC) 4.53%
Revenue Per Employee 7.41M
Profits Per Employee -263,483
Employee Count29
Asset Turnover 1.14
Inventory Turnover 1.97

Taxes

Income Tax -2.30M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -42.80% in the last 52 weeks. The beta is 0.25, so CPH:SMSMED's price volatility has been lower than the market average.

Beta (5Y) 0.25
52-Week Price Change -42.80%
50-Day Moving Average 3.10
200-Day Moving Average 3.82
Relative Strength Index (RSI) 42.12
Average Volume (20 Days) 28,380

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CPH:SMSMED had revenue of DKK 214.99 million and -7.64 million in losses. Loss per share was -0.28.

Revenue214.99M
Gross Profit 27.32M
Operating Income -6.82M
Pretax Income -9.94M
Net Income -7.64M
EBITDA 2.97M
EBIT -6.82M
Loss Per Share -0.28
Full Income Statement

Balance Sheet

The company has 1.45 million in cash and 73.98 million in debt, with a net cash position of -72.53 million or -2.61 per share.

Cash & Cash Equivalents 1.45M
Total Debt 73.98M
Net Cash -72.53M
Net Cash Per Share -2.61
Equity (Book Value) 72.85M
Book Value Per Share 2.62
Working Capital 40.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.69 million and capital expenditures -18.93 million, giving a free cash flow of -23.62 million.

Operating Cash Flow -4.69M
Capital Expenditures -18.93M
Depreciation & Amortization 9.68M
Net Borrowing 24.51M
Free Cash Flow -23.62M
FCF Per Share -0.85
Full Cash Flow Statement

Margins

Gross margin is 12.71%, with operating and profit margins of -3.17% and -3.55%.

Gross Margin 12.71%
Operating Margin -3.17%
Pretax Margin -4.62%
Profit Margin -3.55%
EBITDA Margin 1.38%
EBIT Margin -3.17%
FCF Margin n/a

Dividends & Yields

CPH:SMSMED does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -9.61%
FCF Yield -29.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CPH:SMSMED has an Altman Z-Score of 2.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.3
Piotroski F-Score 1